An evaluation of measles revaccination among school-entry-aged children

Pediatrics

Volumn 97, Issue 5, 1996, Pages 613-618

  Watson, John C ^a,c   Pearson, John A ^b   Markowitz, Lauri E ^c   Baughman, Andrew L ^c   Erdman, Dean D ^d   Bellini, William J ^d   Baron, Roy C ^a   Fleming, David W ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KAISER PERMANENTE   (United States)

^c CENTERS FOR DIS CONTR AND PREV   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e OREGON PUBLIC HEALTH DIVISION   (United States)

Author keywords

cost effectiveness; immunity; measles; measles vaccine; revaccination

Indexed keywords

MEASLES VACCINE;

ANTIBODY DETECTION; ARTICLE; CASE CONTROL STUDY; CHILD; COST BENEFIT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEROEPIDEMIOLOGY;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; EDUCATIONAL STATUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MEASLES VACCINE; MEASLES VIRUS; MOTHERS; NEUTRALIZATION TESTS; VACCINATION;

EID: 0029871510     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gustafson TL, Lievens AW, Brunell PA, et al. Measles outbreak in a fully immunized secondary-school population. N Engl J Med. 1987;316: 771-774
2. Hull HF, Montes BA, Hays BS, Lucero RL Risk factors for measles vaccine failure among immunized students. Pediatrics. 1985;76:518-523
3. Edmonson MB, Addiss DG, McPherson JT, Berg JL, Circo SR, Davis JP. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA. 1990;263:2467-2471
4. Markowitz LE, Preblud SR, Fine PEM, Orenstein WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J. 1990;9:101-110
5. Markowitz LE, Preblud SR, Orenstein WA, et al. Patterns of transmission in measles outbreaks in the United States, 1985-86. N Engl J Med. 1989;320:75-81
6. Hutchins SS, Markowitz LE, Mead P, et al. A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure. Am J Epidemtol. 1990;132:157-168
7. Frank JA Jr, Orenstein WA, Bart KJ, et al Major impediments to measles elimination: the modern epidemiology of an ancient disease. Am J Dis Child. 1985;139 881-888
8. CDC. Measles Prevention. Recommendations of the Immunization Practices Advisory Committee (ACIP) MMWR 1989;38(S-9):1-18
9. Krugman S, Giles JP, Jacobs AM, Friedman H. Studies with a further attenuated live measles-virus vaccine. Pediatrics. 1963;31:919-928
10. Lingam S, Miller CL, Clarke M, Pateman J. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin. Br Med J. 1986,292:1044-1045
11. Heymann DL, Smith EL, Nakano JH, Jato JG, Martin GE, Kesseng-Magen G. Further field testing of the more heat-stable measles vaccines in Cameroon. Br Med J. 1982;285:531-533
12. Mann GF, Allison LMC, Lloyd JS, Tam P, Zuckerman AJ, Perkins FT. Stability of further-attenuated measles vaccines. Rev Infect Dis 1983;5: 482-486
13. Erdman DD, Anderson LJ, Adams DR, Stewart JA, Markowitz LE, Bellini WJ Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol. 1991;29:1466-1471
14. Anderson LJ, Hierholzer JC, Bingham PG, Stone YO. Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay J Clin Microbiol 1985;22:1050-1052
15. Erdman DD, Heath JL, Watson JC, Markowitz LE, Bellini WJ Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J Med Virol 1993;41 44-48
16. Chen RT, Markowitz LE, Albrecht P Measles antibody reevaluation of protective titers J Infect Dis. 1990;162:1036-1042
17. SAS Institute Inc, The LOGISTIC procedure. In: SASISTAT User's Guide, Version 6 (4th edition). Cary, NC. SAS Institute Inc, 1989:1071-1126
18. Markowitz LE, Albrecht P, Orenstein WA, Lett SM, Pugliese TJ, Farrell D Persistence of measles antibody after revaccination. J Infect Dis 1992,166.205-208
19. Orenstein WA, Albrecht P, Herrmann KL, Bernier R, Bart KJ, Rovira EZ. The plaque-neutralization test as a measure of prior exposure to measles virus J Infect Dis 1987,155 146-149
20. Wittler RR, Veit BC, McIntyre S, Schydlower M Measles revaccination response in a school-age population. Pediatrics. 1991;88.1024-1030
21. Hethcote HW. Measles and rubella in the United States. Am J Epidemtol. 1983:117-2-13
22. Bart KJ, Orenstein WA, Hinman AR, Amler RW. Measles and models. Int J Epidemtol. 1983;12:203-266
23. Albrecht P, Ennis FA, Saltzman EJ, Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr. 1977;91:715-718
24. Baughman AL, Williams WW, Atkinson WL, Cook LG, Collins M. The impact of college prematriculation immunization requirements on risk for measles outbreaks. JAMA. 1994,272:1127-1132
25. Atkinson WL, Markowitz LE, Baughman AL. Serologic response to measles vaccination among ill children (abstract 422). Presented at the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, October 11-14, 1992; Anaheim, CA
26. King G, Markowitz LE, Heath J Antibody response to measles. mumps, and rubella vaccine of well children and children with upper respiratory tract infection and other minor illnesses (abstract 1424) Presented at the 33rd Interscience Conference on Antimicrobial Agents, and Chemotherapy, October 17-20, 1993; New Orleans, LA
27. Krober MS, Stracener CE, Bass JW. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds. JAMA 1991;265:2095-2096
28. National Vaccine Advisory Committee. The measles epidemic the problems, barriers, and recommendations. JAMA. 1991;266:1547-1552